In 2001, the Laboratory for the Study of lipids in the National Center of Hygiene, Medical Ecology and Nutrition tested clinically BiostimN effect on lipids and blood sugar of patients suffering from dyslipidemia and diabetes. After 60 days of dosing, average scores of total cholesterol, LDL-cholesterol and blood sugar of patients in the group fell significantly. The patients felt better and communicated a certain relaxing effect, improved sleep, normalized blood pressure and reduced stress, which is very important in correcting the distortions of metabolism (lipid-glucose metabolism). As a doctor, I consider Biostim-N a very appropriate supportive therapy /accompanying the primary therapy/ for slowing the progression of arteriosclerosis and reducing the risk of clinical complications. I began prescribing this product to my patients as a therapy in my practice.